People · Operator

Antonio Costanzo

Named in public records as an officer, director or promoter · active 2018–2021 · Other, Healthtech

2
Companies
7
Filings
$46.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
EMMAC Life Sciences LtdOtherSeries A$28.4M$3.1M2018
Yooma Wellness Inc.HealthtechSeries A$17.7M$19.2M2021
Operator network

Antonio Costanzo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Barbara Pacchetti · 1 companies · 1 sharedBarbara PacchettiEdward McDermott · 1 companies · 1 sharedEdward McDermottOrr Yarkoni · 1 companies · 1 sharedOrr YarkoniThomas Ellen · 1 companies · 1 sharedThomas EllenThomas Rooke · 1 companies · 1 sharedThomas RookeLorne Abony · 3 companies · 2 sharedLorne AbonyMichael Young · 10 companies · 1 sharedMichael YoungAnthony Lacavera · 3 companies · 1 sharedAnthony LacaveraJordan Greenberg · 3 companies · 1 sharedJordan GreenbergJoshua Lebovic · 3 companies · 1 sharedJoshua LebovicAntonio Costanza · 1 companies · 1 sharedAntonio CostanzaRon Wardle · 1 companies · 1 sharedRon WardleSimon Dryan · 1 companies · 1 sharedSimon DryanEMMAC Life Sciences Ltd · $28.4M raisedEMMAC Life Sciences L…Yooma Wellness Inc. · $17.7M raisedYooma Wellness Inc.Antonio CostanzoAC
Antonio Costanzo Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Antonio Costanzo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Lorne Abony23
Michael Young110
Jordan Greenberg13
Joshua Lebovic13
Anthony Lacavera13
Simon Dryan11
Orr Yarkoni11
Ron Wardle11
Thomas Ellen11
Thomas Rooke11
Edward McDermott11
Barbara Pacchetti11
Antonio Costanza11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.